310 related articles for article (PubMed ID: 33622418)
1. Frontotemporal lobar degeneration proteinopathies have disparate microscopic patterns of white and grey matter pathology.
Giannini LAA; Peterson C; Ohm D; Xie SX; McMillan CT; Raskovsky K; Massimo L; Suh E; Van Deerlin VM; Wolk DA; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
Acta Neuropathol Commun; 2021 Feb; 9(1):30. PubMed ID: 33622418
[TBL] [Abstract][Full Text] [Related]
2. White matter imaging helps dissociate tau from TDP-43 in frontotemporal lobar degeneration.
McMillan CT; Irwin DJ; Avants BB; Powers J; Cook PA; Toledo JB; McCarty Wood E; Van Deerlin VM; Lee VM; Trojanowski JQ; Grossman M
J Neurol Neurosurg Psychiatry; 2013 Sep; 84(9):949-55. PubMed ID: 23475817
[TBL] [Abstract][Full Text] [Related]
3. Divergent Histopathological Networks of Frontotemporal Degeneration Proteinopathy Subytpes.
Chen M; Ohm DT; Phillips JS; McMillan CT; Capp N; Peterson C; Xie E; Wolk DA; Trojanowski JQ; Lee EB; Gee J; Grossman M; Irwin DJ
J Neurosci; 2022 May; 42(18):3868-3877. PubMed ID: 35318284
[TBL] [Abstract][Full Text] [Related]
4. Typical and atypical pathology in primary progressive aphasia variants.
Spinelli EG; Mandelli ML; Miller ZA; Santos-Santos MA; Wilson SM; Agosta F; Grinberg LT; Huang EJ; Trojanowski JQ; Meyer M; Henry ML; Comi G; Rabinovici G; Rosen HJ; Filippi M; Miller BL; Seeley WW; Gorno-Tempini ML
Ann Neurol; 2017 Mar; 81(3):430-443. PubMed ID: 28133816
[TBL] [Abstract][Full Text] [Related]
5. Signature laminar distributions of pathology in frontotemporal lobar degeneration.
Ohm DT; Cousins KAQ; Xie SX; Peterson C; McMillan CT; Massimo L; Raskovsky K; Wolk DA; Van Deerlin VM; Elman L; Spindler M; Deik A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
Acta Neuropathol; 2022 Mar; 143(3):363-382. PubMed ID: 34997851
[TBL] [Abstract][Full Text] [Related]
6. Divergent patterns of TDP-43 and tau pathologies in primary progressive aphasia.
Giannini LAA; Xie SX; McMillan CT; Liang M; Williams A; Jester C; Rascovsky K; Wolk DA; Ash S; Lee EB; Trojanowski JQ; Grossman M; Irwin DJ
Ann Neurol; 2019 May; 85(5):630-643. PubMed ID: 30851133
[TBL] [Abstract][Full Text] [Related]
7. MRI signatures of the frontotemporal lobar degeneration continuum.
Agosta F; Galantucci S; Magnani G; Marcone A; Martinelli D; Antonietta Volontè M; Riva N; Iannaccone S; Ferraro PM; Caso F; Chiò A; Comi G; Falini A; Filippi M
Hum Brain Mapp; 2015 Jul; 36(7):2602-14. PubMed ID: 25821176
[TBL] [Abstract][Full Text] [Related]
8. Presymptomatic and early pathological features of MAPT-associated frontotemporal lobar degeneration.
Giannini LA; Mol MO; Rajicic A; van Buuren R; Sarkar L; Arezoumandan S; Ohm DT; Irwin DJ; Rozemuller AJ; ; van Swieten JC; Seelaar H
Acta Neuropathol Commun; 2023 Aug; 11(1):126. PubMed ID: 37533060
[TBL] [Abstract][Full Text] [Related]
9. Ex vivo MRI and histopathology detect novel iron-rich cortical inflammation in frontotemporal lobar degeneration with tau versus TDP-43 pathology.
Tisdall MD; Ohm DT; Lobrovich R; Das SR; Mizsei G; Prabhakaran K; Ittyerah R; Lim S; McMillan CT; Wolk DA; Gee J; Trojanowski JQ; Lee EB; Detre JA; Yushkevich P; Grossman M; Irwin DJ
Neuroimage Clin; 2022; 33():102913. PubMed ID: 34952351
[TBL] [Abstract][Full Text] [Related]
10. Degeneration of the locus coeruleus is a common feature of tauopathies and distinct from TDP-43 proteinopathies in the frontotemporal lobar degeneration spectrum.
Ohm DT; Peterson C; Lobrovich R; Cousins KAQ; Gibbons GS; McMillan CT; Wolk DA; Van Deerlin V; Elman L; Spindler M; Deik A; Siderowf A; Trojanowski JQ; Lee EB; Grossman M; Irwin DJ
Acta Neuropathol; 2020 Nov; 140(5):675-693. PubMed ID: 32804255
[TBL] [Abstract][Full Text] [Related]
11. Ante mortem cerebrospinal fluid tau levels correlate with postmortem tau pathology in frontotemporal lobar degeneration.
Irwin DJ; Lleó A; Xie SX; McMillan CT; Wolk DA; Lee EB; Van Deerlin VM; Shaw LM; Trojanowski JQ; Grossman M
Ann Neurol; 2017 Aug; 82(2):247-258. PubMed ID: 28719018
[TBL] [Abstract][Full Text] [Related]
12. Concurrent tau pathologies in frontotemporal lobar degeneration with TDP-43 pathology.
Koga S; Zhou X; Murakami A; Fernandez De Castro C; Baker MC; Rademakers R; Dickson DW
Neuropathol Appl Neurobiol; 2022 Feb; 48(2):e12778. PubMed ID: 34823271
[TBL] [Abstract][Full Text] [Related]
13. In vivo signatures of nonfluent/agrammatic primary progressive aphasia caused by FTLD pathology.
Caso F; Mandelli ML; Henry M; Gesierich B; Bettcher BM; Ogar J; Filippi M; Comi G; Magnani G; Sidhu M; Trojanowski JQ; Huang EJ; Grinberg LT; Miller BL; Dronkers N; Seeley WW; Gorno-Tempini ML
Neurology; 2014 Jan; 82(3):239-47. PubMed ID: 24353332
[TBL] [Abstract][Full Text] [Related]
14. Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration.
Woollacott IOC; Toomey CE; Strand C; Courtney R; Benson BC; Rohrer JD; Lashley T
J Neuroinflammation; 2020 Aug; 17(1):234. PubMed ID: 32778130
[TBL] [Abstract][Full Text] [Related]
15. Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration.
Giannini LAA; Ohm DT; Rozemuller AJM; Dratch L; Suh E; van Deerlin VM; Trojanowski JQ; Lee EB; van Swieten JC; Grossman M; Seelaar H; Irwin DJ;
Acta Neuropathol; 2022 Dec; 144(6):1065-1084. PubMed ID: 36066634
[TBL] [Abstract][Full Text] [Related]
16. Empiric Methods to Account for Pre-analytical Variability in Digital Histopathology in Frontotemporal Lobar Degeneration.
Giannini LAA; Xie SX; Peterson C; Zhou C; Lee EB; Wolk DA; Grossman M; Trojanowski JQ; McMillan CT; Irwin DJ
Front Neurosci; 2019; 13():682. PubMed ID: 31333403
[TBL] [Abstract][Full Text] [Related]
17. Diffuse argyrophilic grain disease with TDP-43 proteinopathy and neuronal intermediate filament inclusion disease: FTLD with mixed tau, TDP-43 and FUS pathologies.
Koga S; Murakami A; Soto-Beasley AI; Walton RL; Baker MC; Castanedes-Casey M; Josephs KA; Ross OA; Dickson DW
Acta Neuropathol Commun; 2023 Jul; 11(1):109. PubMed ID: 37415197
[TBL] [Abstract][Full Text] [Related]
18. Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.
Irwin DJ; Cairns NJ; Grossman M; McMillan CT; Lee EB; Van Deerlin VM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Apr; 129(4):469-91. PubMed ID: 25549971
[TBL] [Abstract][Full Text] [Related]
19. Phases of volume loss in patients with known frontotemporal lobar degeneration spectrum pathology.
Burke SE; Phillips JS; Olm CA; Peterson CS; Cook PA; Gee JC; Lee EB; Trojanowski JQ; Massimo L; Irwin DJ; Grossman M
Neurobiol Aging; 2022 May; 113():95-107. PubMed ID: 35325815
[TBL] [Abstract][Full Text] [Related]
20. Mixed TDP-43 proteinopathy and tauopathy in frontotemporal lobar degeneration: nine case series.
Kim EJ; Brown JA; Deng J; Hwang JL; Spina S; Miller ZA; DeMay MG; Valcour V; Karydas A; Ramos EM; Coppola G; Miller BL; Rosen HJ; Seeley WW; Grinberg LT
J Neurol; 2018 Dec; 265(12):2960-2971. PubMed ID: 30324308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
